The Role of Cyclosporine in Blood Cell Transplants With T-Cell Add-Back for Blood Cancers

Clinical trial NCT00001873 · COMPLETED

Trial details

NCT number: NCT00001873
Sponsor: National Heart, Lung, and Blood Institute (NHLBI)
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Chronic Lymphocytic Leukemia Graft vs Host Disease Hematologic Neoplasm Multiple Myeloma Myelodysplastic Syndrome

Start date: 1999-02-22
Primary completion: 2007-12-28
Enrollment: 102

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.